IL325937A - Aav-delivered antibodies and methods of use thereof - Google Patents
Aav-delivered antibodies and methods of use thereofInfo
- Publication number
- IL325937A IL325937A IL325937A IL32593726A IL325937A IL 325937 A IL325937 A IL 325937A IL 325937 A IL325937 A IL 325937A IL 32593726 A IL32593726 A IL 32593726A IL 325937 A IL325937 A IL 325937A
- Authority
- IL
- Israel
- Prior art keywords
- aav
- methods
- delivered antibodies
- antibodies
- delivered
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363515218P | 2023-07-24 | 2023-07-24 | |
| PCT/US2024/039323 WO2025024541A2 (en) | 2023-07-24 | 2024-07-24 | Aav-delivered antibodies and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL325937A true IL325937A (en) | 2026-03-01 |
Family
ID=94375705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL325937A IL325937A (en) | 2023-07-24 | 2024-07-24 | Aav-delivered antibodies and methods of use thereof |
Country Status (2)
| Country | Link |
|---|---|
| IL (1) | IL325937A (en) |
| WO (1) | WO2025024541A2 (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10350245B2 (en) * | 2015-01-21 | 2019-07-16 | Fred Hutchinson Cancer Research Center | Point-of-care and/or portable platform for gene therapy |
| WO2020097252A1 (en) * | 2018-11-06 | 2020-05-14 | University Of Miami | Compositions and production of recombinant aav viral vectors capable of glycoengineering in vivo |
| WO2020221450A1 (en) * | 2019-04-30 | 2020-11-05 | Humabs Biomed Sa | Antibodies and methods for treatment of influenza a infection |
| CN119173251A (en) * | 2022-04-29 | 2024-12-20 | 库尔制药开发公司 | Tolerogenic immune-modifying nanoparticles for overcoming the immunogenicity of therapeutic carriers and proteins |
-
2024
- 2024-07-24 IL IL325937A patent/IL325937A/en unknown
- 2024-07-24 WO PCT/US2024/039323 patent/WO2025024541A2/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025024541A3 (en) | 2025-04-17 |
| WO2025024541A2 (en) | 2025-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB202019709D0 (en) | Anti-Coronavirus antibodies and methods of use | |
| IL316368A (en) | Anti-tl1a antibodies and methods of use thereof | |
| SMT202500106T1 (en) | Anti-par-2 antibodies and methods of use thereof | |
| IL315845A (en) | Anti-dectin-1 antibodies and methods of use thereof | |
| IL298668B1 (en) | Anti-cd200r1 antibodies and methods of use thereof | |
| IL319590A (en) | Multispecific antibodies and methods of use thereof | |
| IL316065A (en) | Anti-cd28 antibodies and methods of use thereof | |
| IL317690A (en) | Anti-gpnmb antibodies and methods of use thereof | |
| IL318694A (en) | Anti-ccr8 antibodies and methods of use | |
| IL308260A (en) | Anti-tigit antibodies and methods of use thereof | |
| IL325937A (en) | Aav-delivered antibodies and methods of use thereof | |
| IL318357A (en) | Anti- il27r antibodies and methods of use thereof | |
| IL316700A (en) | Anti-bmp9 antibodies and methods of use thereof | |
| IL316894A (en) | Anti-tnfr2 antibodies and methods of use thereof | |
| IL321679A (en) | Anti-ror-2 antibodies and methods of use | |
| IL310551A (en) | Osmr-specific monoclonal antibodies and methods of their use | |
| IL311003A (en) | Anti-her2 antibodies and methods of use thereof | |
| IL325840A (en) | Bispecific pd-l1xcd28 antibodies and methods of use thereof | |
| IL325837A (en) | Bispecific pd-l1x4-1bb antibodies and methods of use thereof | |
| GB202204813D0 (en) | Human monoclonal antibodies and methods of use thereof | |
| GB202204736D0 (en) | Human monoclonal antibodies and methods of use thereof | |
| CA3303930A1 (en) | Anti-nectin-4 antibodies and methods of use thereof | |
| CA3298139A1 (en) | Aav-delivered antibodies and methods of use thereof | |
| CA3292076A1 (en) | Anti-toh1 antibodies and methods of use thereof | |
| CA3286084A1 (en) | Anti-cd161 antibodies and methods of use thereof |